Literature DB >> 8207235

Analysis of binding of monoclonal antibody to a malarial peptide by surface plasmon resonance biosensor and integrated rate equations.

R M Wohlhueter1, K Parekh, V Udhayakumar, S Fang, A A Lal.   

Abstract

Using biosensor technology and integrated rate equations, we have developed procedures to determine the kinetic parameters and equilibrium affinity constant of Ag-Ab interactions. The Ag used in these studies was a peptide that represents the major B cell epitope of the circumsporozoite protein of Plasmodium falciparum, a promising malaria vaccine candidate Ag. Measurements of association and dissociation rate constants of this peptide with the mAb 2A10 were determined by fitting integrated rate equations to binding data obtained with a BIAcore surface plasmon-resonance biosensor. We examined whether accurate estimates of initial velocity and final equilibrium levels of binding of Ab to peptides can be obtained using these methods, and whether kinetic rates and equilibrium constants obtained with systematic variation of the experimental parameters conform to a simple bimolecular model of binding. We found that initial velocity was approximately first order with respect to Ab concentration. When we used a series of four sensor cells with different peptides loads, however, we found that the initial velocity of binding appeared to be nearly independent of peptide concentration. Equilibrium analyses yielded dissociation constants of approximately 3 x 10(-7) M. Integrated rate treatment of biosensor data supports a critical examination of the assumptions on which the binding models are based and suggests a need to refine such models. Nevertheless, it provides a powerful quantitative tool for assessing the Ag-Ab binding reaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8207235

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data.

Authors:  D G Myszka; X He; M Dembo; T A Morton; B Goldstein
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

2.  Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport.

Authors:  P Schuck
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

3.  Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties.

Authors:  Rasmus Lundquist; Leif Kofoed Nielsen; Ali Jafarshad; Daw Soesoe; Lars Harder Christensen; Pierre Druilhe; Morten Hanefeld Dziegiel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine.

Authors:  Y P Shi; S E Hasnain; J B Sacci; B P Holloway; H Fujioka; N Kumar; R Wohlhueter; S L Hoffman; W E Collins; A A Lal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

5.  Surface engineering: optimization of antigen presentation in self-assembled monolayers.

Authors:  C Duschl; A F Sévin-Landais; H Vogel
Journal:  Biophys J       Date:  1996-04       Impact factor: 4.033

6.  Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.

Authors:  So-Hee Kim; Seung-Young Hwang; Yong-Seok Lee; In-Hak Choi; Sae-Gwang Park; Weon-Gyu Kho
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

7.  How Should Antibodies against P. falciparum Merozoite Antigens Be Measured?

Authors:  Sriwipa Chuangchaiya; Kristina E M Persson
Journal:  J Trop Med       Date:  2013-04-18

8.  Structural and thermodynamic approach to peptide immunogenicity.

Authors:  Carlos J Camacho; Yasuhiro Katsumata; Dana P Ascherman
Journal:  PLoS Comput Biol       Date:  2008-11-21       Impact factor: 4.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.